Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Hologic.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 20/20 Bioresponse, Adm Tronics Unlimited, Ambu, Anpac Bio-Medical Science, Capillary Biomedical, Cb2 Insights, Decipher Biosciences, lectromedical Technologies, Ellume, Evicore Healthcare, Exact Sciences, Exonbio, Imagin Medical, Imed Surgical, Lequest, Lighthouse Imaging, Maverick County Medical, Medicine Discovery Catapult, Integrated Health, Oncimmune, Oncomfort, Origin, Orthex, Orthopediatrics, Paley Orthopedic and Spine Institute, Pfizer, Polarean Imaging, Philips, Qosina, Quanterix, Resolution Medical, Sonic Healthcare, Squadron Capital, Synthace, Todos Medical, Ubiquitome, Vygon.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Medmira, Pulse Biosciences.

With COVID-19 cases once again surging across the globe and several countries considering targeted lockdowns, vaccines remain the best hope of restoring a sense of normalcy amidst the pandemic. For vaccines to work though, people must have enough confidence in the efficacy and safety that they’re willing to get vaccinated when the vaccines become available. That’s why the emergency use authorization (EUA) guidance the FDA released Oct. 6 for COVID-19 vaccines is so important.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aprea, Arca, Arch, Biomarin, Eton, Lilly, OWP, Pluristem, Polarean, TLC, Y-Mabs.